Back to Market Feed

BRIVIACT 50 MG TABLET

$24.0911per EA

DEA Schedule CV

Strength

50 mg/1

Manufacturer

NDC

50474057009

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

Approval Type

New Drug (NDA)

FDA Application

On Market Since

5/12/2016

Pharmacological Classes

Epoxide Hydrolase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.6%

1Y

+2.5%

3Y

+9.7%

5Y

+24.3%

All

+50.9%

Generic Alternatives

1 alternative • Same active ingredient

BRIVIACT 50 MG TABLET

50474057066•UCB, Inc.

Related Drugs

Same classification

No related drugs found.